HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arani Chatterjee Selected Research

DRF-1042

4/2005Safety, tolerability, and pharmacokinetics of a capsule formulation of DRF-1042, a novel camptothecin analog, in refractory cancer patients in a bridging phase I study.
7/2004Safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally active novel camptothecin analog, DRF-1042, in refractory cancer patients in a phase I dose escalation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arani Chatterjee Research Topics

Disease

2Poliomyelitis (Polio)
12/2015 - 08/2011
2Neoplasms (Cancer)
04/2005 - 07/2004
1Vaginal Discharge
10/2009
1Infections
12/2005

Drug/Important Bio-Agent (IBA)

2Oral Poliovirus Vaccine (Sabin Vaccine)IBA
12/2015 - 12/2005
2DRF-1042IBA
04/2005 - 07/2004
2CamptothecinIBA
04/2005 - 07/2004
1Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link
12/2015
1Poliovirus VaccinesIBA
08/2011
1Povidone-Iodine (Betadine)FDA LinkGeneric
10/2009
1PraneemIBA
10/2009
1Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA
10/2009
1Capsules (Microcapsules)IBA
04/2005

Therapy/Procedure

1Pessaries
10/2009